Showing results (71-80 of 148) with videos related to
Sort By:
Pageof 15
Journal of Fungi (Basel, Switzerland)|April 28, 2023
The Amylolytic Regulator AmyR of Aspergillus niger Is Involved in Sucrose and Inulin Utilization in a Culture-Condition-Dependent MannerRoland S Kun, Sonia Salazar-Cerezo, Mao Peng, et al.FEMS Microbiology Ecology|March 31, 2023
Acquisition of host-derived carbon in biomass of the ectomycorrhizal fungus Pisolithus microcarpus is correlated to fungal carbon demand and plant defencesEmiko K Stuart, Vasanth Singan, Mojgan Amirebrahimi, et al.Journal of Neurochemistry|January 14, 2010
Wild-type Shadoo proteins convert to amyloid-like forms under native conditionsNathalie Daude, Vivian Ng, Joel C Watts, et al.Gastroenterology|February 5, 2008
A molecular signature of gastric metaplasia arising in response to acute parietal cell lossKoji Nozaki, Masako Ogawa, Janice A Williams, et al.Journal of Biotechnology|November 29, 2019
Mixtures of aromatic compounds induce ligninolytic gene expression in the wood-rotting fungus Dichomitus squalensPaul Daly, Mao Peng, Sara Casado López, et al.Environmental Microbiology|November 13, 2020
Intra-species genetic variability drives carbon metabolism and symbiotic host interactions in the ectomycorrhizal fungus Pisolithus microcarpusKrista L Plett, Annegret Kohler, Teresa Lebel, et al.Frontiers in Bioengineering and Biotechnology|October 16, 2019
Cinnamic Acid and Sorbic acid Conversion Are Mediated by the Same Transcriptional Regulator in Aspergillus nigerRonnie J M Lubbers, Adiphol Dilokpimol, Jorge Navarro, et al.Microbial Biotechnology|March 5, 2021
Revisiting a 'simple' fungal metabolic pathway reveals redundancy, complexity and diversityTania Chroumpi, Mao Peng, Maria Victoria Aguilar-Pontes, et al.JACC. Advances|June 28, 2024
FEops HEARTguide Patient-Specific Computational Simulations for WATCHMAN FLX Left Atrial Appendage Closure: A Retrospective StudyLauren S Ranard, Torsten P Vahl, Robert Sommer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 6, 2013
Phase II randomized study of trastuzumab emtansine versus trastuzumab plus docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancerSara A Hurvitz, Luc Dirix, Judit Kocsis, et al.Pageof 15